Maurice J. Dewald

Maurice J. Dewald discloses dealings in 6 companies, chiefly Healthcare Trust of America, Inc., Nextgen Healthcare, Inc. and Targeted Medical Pharma, Inc. Over a trading history stretching from 6 September 2006 to 9 July 2019, the count stands at 29 filings.

On the open market, the record shows 5 purchases worth €207k and 2 sales worth €1.4M. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 19 share grants and 3 option exercises.

In size, the median ticket on the buying side is €48k.

The record was last updated on 9 July 2019 with a share grant (€89k) in Healthcare Trust of America, Inc. The last insider purchase was made public on 6 May 2014, 4,554 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.